An alternative form of melarsoprol in sleeping sicknessKENNEDY, Peter G. E.Trends in parasitology. 2012, Vol 28, Num 8, pp 307-310, issn 1471-4922, 4 p.Article

Physico-chemical properties of the trypanocidal drug melarsoprolKEISER, J; BURRI, C.Acta tropica. 2000, Vol 74, Num 1, pp 101-104, issn 0001-706XArticle

Melarsoprol refractory T. b. gambiense from Omugo, north-western UgandaMATOVU, E; ENYARU, J. C. K; LEGROS, D et al.TM & IH. Tropical medicine & international health. 2001, Vol 6, Num 5, pp 407-411, issn 1360-2276Article

An automated biological assay to determine levels of the trypanocidal drug melarsoprol in biological fluidsONYANGO, J. D; BURRI, C; BRUN, R et al.Acta tropica. 2000, Vol 74, Num 1, pp 95-100, issn 0001-706XArticle

Melarsoprol-and pentamidine-resistant Trypanosoma brucei rhodesiense populations and their cross-resistanceBERNHARD, Sonja C; NERIMA, Barbara; MÄSER, Pascal et al.International journal for parasitology. 2007, Vol 37, Num 13, pp 1443-1448, issn 0020-7519, 6 p.Article

The melaminophenyl arsenicals melarsoprol and melarsen oxide interfere with thiamine metabolism in the fission yeast Schizosaccharomyces pombeSCHWEINGRUBER, M. Ernst.Antimicrobial agents and chemotherapy. 2004, Vol 48, Num 9, pp 3268-3271, issn 0066-4804, 4 p.Article

Update on field use of the available drugs for the chemotherapy of human African trypanosomiasisSIMARRO, P. P; FRANCO, J; DIARRA, A et al.Parasitology (London. Print). 2012, Vol 139, Num 7, pp 842-846, issn 0031-1820, 5 p.Article

Melarsoprol-associated multifocal inflammatory CNS illness in African I trypanosomiasisKUMAR, N; ORENSTEIN, R; USLAN, D. Z et al.Neurology. 2006, Vol 66, Num 7, pp 1120-1121, issn 0028-3878, 2 p.Article

Effectiveness of a 10-day melarsoprol schedule for the treatment of late-stage human African trypanosomiasis : Confirmation from a multinational study (IMPAMEL II). CommentaryMOORE, Anne C; SCHMID, Caecilia; SIMARRO, Pere P et al.The Journal of infectious diseases. 2005, Vol 191, Num 11, pp 1793-1795, issn 0022-1899, 13 p.Article

Melarsoprol-cyclodextrins inclusion complexesGIBAUD, Stéphane; BEN ZIRAR, Siham; MUTZENHARDT, Pierre et al.International journal of pharmaceutics. 2005, Vol 306, Num 1-2, pp 107-121, issn 0378-5173, 15 p.Article

Organoarséniés dérivés du 2-phényl-[1,3,2 ]dithiarsolane -4 -yl -méthanol (As^III) à propriétés antileucémiques : des trypanosomicides aux anticancéreux = Organoarsenicals derived from 2-phenyl-[1,3,2]dithiarsolan-4-yl-methanol (As^III) with antileukaemic properties : from trypanosomicides to anticancer drugsGIBAUD, S; ASTIER, A.Annales pharmaceutiques françaises. 2007, Vol 65, Num 3, pp 162-168, issn 0003-4509, 7 p.Conference Paper

Genotypic and phenotypic characterization of Trypanosoma brucei gambiense isolates from Ibba, South Sudan, an area of high melarsoprol treatment failure rateMAINA, Naomi; MAINA, Kagira Joseph; MASER, Pascal et al.Acta tropica. 2007, Vol 104, Num 2-3, pp 84-90, issn 0001-706X, 7 p.Article

Efficacy of 10-day melarsoprol schedule 2 years after treatment for late-stage gambiense sleeping sicknessSCHMID, C; NKUNKU, S; MEROLLE, A et al.Lancet (British edition). 2004, Vol 364, Num 9436, pp 789-790, issn 0140-6736, 2 p.Article

Échecs thérapeutiques du mélarsoprol parmi des patients traités au stade tardif de trypanosomose humaine africaine à T. b. gambiense en Ouganda = Therapeutic failure of melarsoprol among patients treated for late stage of T. b. gambiense human African trypanosomiasis in UgandaLEGROS, D; FOURNIER, C; ETCHEGORRY, M. G et al.Bulletin de la Société de pathologie exotique. 1999, Vol 92, Num 3, pp 171-172, issn 0037-9085Article

Trypanosoma brucei : Lack of cross-resistance to melarsoprol in vitro by cymelarsan-resistant parasitesSCOTT, A. G; TAIT, A; TURNER, C. M. R et al.Experimental parasitology. 1997, Vol 86, Num 3, pp 181-190, issn 0014-4894Article

Comparison of nanosuspensions and hydroxypropyl-β-cyclodextrin complex of melarsoprol : Pharmacokinetics and tissue distribution in miceBEN ZIRAR, Siham; ASTIER, Alain; MUCHOW, Marc et al.European journal of pharmaceutics and biopharmaceutics. 2008, Vol 70, Num 2, pp 649-656, issn 0939-6411, 8 p.Article

The phenomenon of treatment failures in Human African TrypanosomiasisBRUN, Reto; SCHUMACHER, Reto; SCHMID, Cecile et al.TM & IH. Tropical medicine & international health. 2001, Vol 6, Num 11, pp 906-914, issn 1360-2276Conference Paper

Clinical study of an organic arsenical, melarsoprol, in patients with advanced leukemiaSOIGNET, S. L; TONG, W. P; HIRSCHFELD, S et al.Cancer chemotherapy and pharmacology. 1999, Vol 44, Num 5, pp 417-421, issn 0344-5704Article

Old and new therapies in chronic lymphocytic leukemia : Now is the time for a reassessment of therapeutic goalsBYRD, J. C; RAI, K. R; SAUSVILLE, E. A et al.Seminars in oncology. 1998, Vol 25, Num 1, pp 65-74, issn 0093-7754Article

Attempt to correlate urine arsenic excretion with clinical course during melarsoprol therapy of patients with rhodesian trypanosomiasisHARRISON, S. M; HARRIS, R. W; BALES, J. D et al.The American journal of tropical medicine and hygiene. 1997, Vol 56, Num 6, pp 632-636, issn 0002-9637Article

Effectiveness of melarsoprol and eflornithine as first-line regimens for gambiense sleeping sickness in nine Médecins Sans Frontières programmesBALASEGARAM, Manica; YOUNG, Heather; CHAPPUIS, Francois et al.Transactions of the Royal Society of Tropical Medicine and Hygiene. 2009, Vol 103, Num 3, pp 280-290, issn 0035-9203, 11 p.Article

Efficacy of new, concise schedule for melarsoprol in treatment of sleeping sickness caused by Trypanosoma brucei gambiense: a randomised trialBURRI, C; NKUNKU, S; MEROLLE, A et al.Lancet (British edition). 2000, Vol 355, Num 9213, pp 1419-1425, issn 0140-6736Article

Chemotherapy against human African trypanosomiasis: Is there a road to success?BURRI, Christian.Parasitology (London. Print). 2010, Vol 137, pp 1987-1994, issn 0031-1820, 8 p., 14Article

Comparison of the in vitro drug sensitivity of Trypanosoma brucei gambiense strains from West and Central Africa isolated in the periods 1960-1995 and 1999-2004LEKANE LIKEUFACK, A. C; BRUN, R; FOMENA, A et al.Acta tropica. 2006, Vol 100, Num 1-2, pp 11-16, issn 0001-706X, 6 p.Article

High―throughput decoding of antitrypanosomal drug efficacy and resistanceALSFORD, Sam; ECKERT, Sabine; BAKER, Nicola et al.Nature (London). 2012, Vol 482, Num 7384, pp 232-236, issn 0028-0836, 5 p.Article